Cite Filings / SLXN / 0001178913-26-003085
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
PRE 14A

Proxy Statement (Preliminary)

Silexion Therapeutics Corp · Filed 2026-06-03 · Acc 0001178913-26-003085

Documents 1

  • PRE 14A Proxy Statement (Preliminary) , zk2635493.htm

Around this filing

  • 2026-08-14 PRE 14A Proxy Statement (Preliminary)
  • 2026-06-08 4 CSO and CDO acquired 6,000 shares (grant or award)
  • 2026-06-08 4 CFO and Secretary acquired 7,500 shares (grant or award)
  • 2026-06-03 PRE 14A Proxy Statement (Preliminary)
  • 2026-05-29 SCHEDULE 13D/A Beneficial Ownership Report
  • 2026-05-29 8-K Shareholder rights changed · Bylaws or fiscal year change · Other events
  • 2026-03-30 PRE 14A Proxy Statement (Preliminary)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading zk2635493.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…